This website will offer limited functionality in this browser. We only support the recent versions of major browsers like Chrome, Firefox, Safari, and Edge.

Speaking Engagement

DIA Europe 2020

June 29 - July 3, 2020

Virtual

Tim Wilsdon is speaking during the conference.
For more information on this event, click here.

Related Capabilities

Life Sciences

Share

Tim Wilsdon
Vice President

London
+44-20-7664-3707 twilsdon@crai.co.uk

Life Sciences
CRA Insights

Evidence requirements for orphan drugs

CRA’s Life Sciences Practice focuses on global policy, commercialization, and market access issues dedicated to orphan drug issues, including orphan evidence...
Disruption in Pharma
Articles

Microbiome-Based Therapeutics: Negotiating Key Development Challenges

In this article published in BioProcess International, CRA’s Brian Carpenter, Robert Broadnax, and Andrew Thomson discuss how although the microbiome sector...

Explore our thinking

Rare Disease
Speaking Engagement

November 15-18, 2021

Barcelona, Spain

World Orphan Drug Congress Europe

Looking back 10 years, the rare disease space has significantly evolved with a plethora of innovative orphan drug launches and many patients gaining access to...